Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Adding a second method to PROTACs could improve cancer treatment.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Dutasteride may help shrink prostate cancer tumors.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Tofacitinib might be used to treat hair loss.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Tislelizumab can cause cutaneous lupus erythematosus.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.